Endotoxin Testing Market Size, Business Growth Updates, Trends, Industry Report And Forecast To 2033

"The Business Research Company recently released a comprehensive report on the Global Endotoxin Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The endotoxin testing market size has grown steadily in recent years. It will grow from $2.14 billion in 2023 to $2.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing demand for biologics and biosimilars, growing awareness about the importance of endotoxin testing, growing prevalence of infectious diseases.

The endotoxin testing market size is expected to see strong growth in the next few years. It will grow to $2.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to expansion of the biopharmaceutical industry, increasing investment in research and development of endotoxin testing, global healthcare expansion. Major trends in the forecast period include innovative endotoxin detection tools, adoption of endotoxin testing service, demand for endotoxin testing services.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Market Drivers and Trends:

The increasing number of healthcare-associated infections is expected to propel the growth of the endotoxin testing market going forward. Healthcare-associated infections refer to infections acquired while receiving medical care that were not present at the time of admission to the hospital. Healthcare-associated infections often arise from contaminated medical equipment or procedures, necessitating rigorous testing to ensure patient safety. Endotoxin testing services significantly prevent healthcare-associated infections by assessing the bacterial endotoxin levels in medical equipment, especially injectable pharmaceutical products and implantable medical devices. For instance, in December 2022, according to the United Nations International Children's Emergency Fund (UNICEF), a US-based agency of the United Nations, pneumonia was the infectious disease that killed the most children, taking the lives of over 700,000 of them annually, or around 2,000 per day. Furthermore, in May 2022, according to the World Health Organization, a Switzerland-based agency of the United Nations, 24% of patients are affected by healthcare-associated sepsis every year and 52.3% of those patients treated in an intensive care unit die each year. Therefore, the increasing number of healthcare-associated infections is driving the growth of the endotoxin testing market.

Major companies operating in the endotoxin testing market are focused on adopting new technological solutions to sustain their position in the market. For instance, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology and nutrition manufacturing company, launched the Nebula absorbance reader, a new absorbance microplate reader for streamlined endotoxin and pyrogen testing. The instrument is fully connected with Lonza's most recent WinKQCL software to facilitate data integrity compliance, speed training and lessen validation load. There is no longer a requirement for WinKQCL software users to learn new software to utilize the contemporary reader, reducing training demands. The Nebula Absorbance Reader is an innovative and technologically advanced replacement reader that produces outcomes similar to those frequently observed with the ELx808, the industry-standard absorbance reader that Lorenz no longer offers for sale. Additionally, it is designed to be compatible with and adhere to the exacting requirements of Lonza's absorbance-based endotoxin assays, including the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp

Major Key Players of the Market:
Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

Endotoxin Testing Market 2024 Key Insights:

• Endotoxin Testing is expected to grow to $2.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%.
• Rising Healthcare-Associated Infections Fuel Growth In The Endotoxin Testing Market
• Cutting-Edge Technology Reshapes The Landscape Of Endotoxin Testing Market
• North America was the largest region in the endotoxin testing market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12932&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.